| 0 M | 1 M | 3 M | 6 M | 12 M | p* |
---|---|---|---|---|---|---|
Total (n = 42) | ||||||
 BCVA (LogMAR) | 0.80 ± 0.31 | 0.65 ± 0.35 | 0.56 ± 0.31 | 0.41 ± 0.22 | 0.35 ± 0.17 | < 0.001 |
 BCVAΔ (change) | – | − 0.15 ± 0.26 | − 0.24 ± 0.26 | − 0.40 ± 0.27 | − 0.45 ± 0.24 | |
 CFT (µm) | 555.07 ± 149.63 | 361.79 ± 119.43 | 397.57 ± 169.18 | 337.48 ± 106.06 | 314.21 ± 77.06 | < 0.001 |
 CFTΔ (change) | – | − 193.29 ± 104.55 | − 157.50 ± 126.21 | − 217.60 ± 120.52 | − 228.26 ± 156.79 | |
Nondiabetic (n = 21) | ||||||
 BCVA (LogMAR) | 0.63 ± 0.25 | 0.54 ± 0.42 | 0.42 ± 0.31 | 0.31 ± 0.25 | 0.28 ± 0.17 | < 0.001 |
 BCVAΔ (change) | – | − 0.09 ± 0.23 | − 0.21 ± 0.26 | − 0.32 ± 0.25 | − 0.35 ± 0.17 | |
 CFT (µm) | 494.43 ± 99.73 | 318.67 ± 44.49 | 349.33 ± 94.13 | 329.43 ± 97.62 | 298.71 ± 42.05 | < 0.001 |
 CFTΔ (change) | – | − 175.76 ± 63.41 | − 145.10 ± 125.53 | − 165.00 ± 114.79 | − 195.71 ± 93.23 | |
Diabetic w/o DR (n = 21) | ||||||
 BCVA (LogMAR) | 0.98 ± 0.28 | 0.75 ± 0.21 | 0.70 ± 0.24 | 0.50 ± 0.14 | 0.42 ± 0.13 | < 0.001 |
 BCVAΔ (change) | – | − 0.22 ± 0.27 | − 0.27 ± 0.26 | − 0.47 ± 0.28 | − 0.55 ± 0.26 | |
 CFT (µm) | 615.71 ± 168.01 | 404.90 ± 152.84 | 445.81 ± 211.97 | 345.52 ± 115.73 | 329.71 ± 99.51 | < 0.001 |
 CFTΔ (change) | – | − 210.81 ± 133.20 | − 169.90 ± 128.74 | − 270.19 ± 103.88 | − 260.81 ± 198.69 |